EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

ZBP1 in Neuroinflammation and Neurodegeneration: Z-Nucleic-Acid Sensing, RHIM Signalling and Therapeutic Targeting

Matei Șerban, Corneliu Toader, Răzvan-Adrian Covache-Busuioc

International Journal of Molecular Sciences · 2026

DOI: 10.3390/ijms27167478 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, 2026. Verfasst von Matei Șerban und 2 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of General Medicine, "Carol Davila" University of Medicine and Pharmacy, 050474 Bucharest, Romania. Hauptthemen laut MEDLINE: RNA-Binding Proteins, RNA, Z-Form, Neurodegenerative Diseases, Neuroinflammatory Diseases. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 181 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Publish not Perish.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

In contrast to foreign nucleic acids, some of our own endogenously synthesized nucleic acids may become immunologically active without being considered “foreign”. For example, abnormalities in chromatin organization, transcription termination, ribonucleic acid (RNA) splicing, and RNA editing, together with damage to mitochondrial integrity, may render normally functional deoxyribonucleic acid (DNA) and RNA persistently available and aberrantly structured ligands for innate immunity. Z-DNA-binding protein 1 (ZBP1), recently identified as an important component of this innate immune system, recognizes both left-handed DNA (Z-DNA) and left-handed RNA (Z-RNA) using its tandem Z-alpha (Zα) domains and couples recognition of these conformational states to receptor-interacting serine/threonine-protein kinase 1 (RIPK1)-, receptor-interacting serine/threonine-protein kinase 3 (RIPK3)-, and mixed-lineage kinase domain-like pseudokinase (MLKL)-dependent inflammatory and cell-death pathways. More recent studies have also shown that ZBP1 plays a role in recognizing damaged self-nucleic acids associated with tauopathies, Alzheimer’s disease (AD), traumatic brain injury (TBI), and amyloid-associated neuroinflammation. The nucleic-acid forms associated with these conditions include transposable-element activation, extended repeat-containing transcripts, RNA–RNA duplexes or RNA:DNA hybrids, oxidized mitochondrial DNA (mtDNA), and intercellularly transferred nucleic acids, all of which may exhibit substrate structures compatible with Z-form formation. Signaling by ZBP1 does not occur simply based upon nucleic-acid abundance; rather, signaling occurs after prolonged exposure to a nucleic acid when it persists in a structurally competent state, sufficient receptors are present to bind its exposed regions, the receptor proteoforms are competent to participate in signaling, receptor-interacting protein homotypic interaction motif (RHIM)-dependent assembly occurs, and the appropriate adaptor molecules are present. Furthermore, the identity of the cell type expressing ZBP1 determines whether the response produces RIPK3–MLKL-dependent neuronal injury, microglia-mediated inflammation, apoptosis, or mixed cell death. Finally, competition with adenosine deaminase acting on RNA 1 (ADAR1), melanoma differentiation-associated protein 5 (MDA5), double-stranded RNA-dependent protein kinase (PKR), the cyclic guanosine monophosphate–adenosine monophosphate synthase–stimulator of interferon genes (cGAS–STING) pathway, and other nucleic-acid-sensing proteins divides the available pool of endogenous nucleic acids among the outcomes of immune tolerance, type I interferon (IFN-I) signaling, translational inhibition, neuroinflammation, and necroptosis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

RNA-Binding ProteinsRNA, Z-FormNeurodegenerative DiseasesNeuroinflammatory DiseasesDNA, Z-FormDNA-Binding ProteinsHumansSignal TransductionAnimalsInnate Immunity RecognitionImmunity, InnateReceptor-Interacting Protein Serine-Threonine Kinases

Stichwörter der Autor:innen

ADAR1Alzheimer’s diseaseZ-nucleic acidsZBP1innate immunitymitochondrial DNAnecroptosisneuroinflammation

Substanzen

RNA-Binding ProteinsZBP1 protein, humanDNA, Z-FormDNA-Binding ProteinsReceptor-Interacting Protein Serine-Threonine Kinases

Autor:innen und Institutionen

  • Faculty of General Medicine, "Carol Davila" University of Medicine and Pharmacy, 050474 Bucharest, Romania.
  • Department of Neurosurgery, "Carol Davila" University of Medicine and Pharmacy, 050474 Bucharest, Romania.
  • Department of Vascular Neurosurgery, National Institute of Neurology and Neurovascular Diseases, 077160 Bucharest, Romania.
  • Puls Med Association, 051885 Bucharest, Romania.

Förderung

  • Publish not Perish

Zitieren

APA

Șerban, M., Toader, C., & Covache-Busuioc, R. A. (2026). ZBP1 in Neuroinflammation and Neurodegeneration: Z-Nucleic-Acid Sensing, RHIM Signalling and Therapeutic Targeting. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms27167478

Vancouver

Șerban M, Toader C, Covache-Busuioc RA. ZBP1 in Neuroinflammation and Neurodegeneration: Z-Nucleic-Acid Sensing, RHIM Signalling and Therapeutic Targeting. International Journal of Molecular Sciences. 2026. doi:10.3390/ijms27167478

BibTeX
@article{erban2026,
  author = {Șerban, Matei and Toader, Corneliu and Covache-Busuioc, Răzvan-Adrian},
  title = {ZBP1 in Neuroinflammation and Neurodegeneration: Z-Nucleic-Acid Sensing, RHIM Signalling and Therapeutic Targeting},
  journal = {International Journal of Molecular Sciences},
  year = {2026},
  doi = {10.3390/ijms27167478}
}
Kostenlos starten →